מדינה: ארצות הברית
שפה: אנגלית
מקור: NLM (National Library of Medicine)
OXYCODONE HYDROCHLORIDE (UNII: C1ENJ2TE6C) (OXYCODONE - UNII:CD35PMG570), ACETAMINOPHEN (UNII: 362O9ITL9D) (ACETAMINOPHEN - UNII:362O9ITL9D)
West-Ward Pharmaceuticals Corp
OXYCODONE HYDROCHLORIDE
OXYCODONE HYDROCHLORIDE 5 mg
ORAL
PRESCRIPTION DRUG
ROXICET is indicated for the relief of moderate to moderately severe pain. ROXICET should not be administered to patients with known hypersensitivity to oxycodone, acetaminophen, or any other component of this product. Oxycodone is contraindicated in any situation where opioids are contraindicated including patients with significant respiratory depression (in unmonitored settings or the absence of resuscitative equipment) and patients with acute or severe bronchial asthma or hypercarbia. Oxycodone is contraindicated in the setting of suspected or known paralytic ileus. ROXICET is a Schedule II controlled substance. Oxycodone is a mu-agonist opioid with an abuse liability similar to morphine. Oxycodone, like morphine and other opioids used in analgesia, can be abused and is subject to criminal diversion. Drug addiction is defined as an abnormal, compulsive use, use for non-medical purposes of a substance despite physical, psychological, occupational or interpersonal difficulties resulting from such use, and co
ROXICET™ Tablets, Oxycodone and Acetaminophen Tablets USP (Oxycodone Hydrochloride 5 mg and Acetaminophen 325 mg) White, round, scored tablets (Identified 54 543) NDC 0054-8650-24: Unit dose, 25 tablets per card (reverse numbered), 4 cards per shipper. NDC 0054-4650-25: Bottles of 100 tablets. NDC 0054-4650-29: Bottles of 500 tablets. Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Protect from moisture. Dispense in a tight, light-resistant container, as defined in the USP/NF. ROXICET™ Oral Solution, Oxycodone and Acetaminophen Oral Solution (Oxycodone Hydrochloride 5 mg and Acetaminophen 325 mg Oral Solution per 5 mL) Clear, dark red solution NDC 0054-8648-16: Unit dose Patient Cups™ filled to deliver 5 mL (Oxycodone Hydrochloride 5 mg, Acetaminophen 325 mg), ten 5 mL Patient Cups™ per shelf pack, four shelf packs per shipper. NDC 0054-3686-63: Bottles of 500 mL. Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP/NF. DEA Order Form Required. 4073402//06 Revised October 2013 ©RLI, 2013
Abbreviated New Drug Application
ROXICET- OXYCODONE AND ACETAMINOPHEN TABLET ROXICET- OXYCODONE AND ACETAMINOPHEN SOLUTION WEST-WARD PHARMACEUTICALS CORP ---------- ROXICET™ CII OXYCODONE 5 MG AND ACETAMINOPHEN 325 MG TABLETS, USP OXYCODONE 5 MG AND ACETAMINOPHEN 325 MG ORAL SOLUTION PER 5 ML Rx only BOXED WARNING HEPATOTOXICITY Acetaminophen has been associated with cases of acute liver failure, at times resulting in liver transplant and death. Most of the cases of liver injury are associated with the use of acetaminophen at doses that exceed 4000 milligrams per day, and often involve more than one acetaminophen-containing product. DESCRIPTION Each tablet for oral administration contains: Oxycodone Hydrochloride USP.................................................................. 5 mg+ (+5 mg Oxycodone Hydrochloride is equivalent to 4.4815 mg Oxycodone) Acetaminophen...................................................................................... 325 mg Each 5 mL of oral solution for oral administration contains: Oxycodone Hydrochloride........................................................................ 5 mg+ (+5 mg Oxycodone Hydrochloride is equivalent to 4.4815 mg Oxycodone) Acetaminophen...................................................................................... 325 mg Alcohol ...................................................................................................... 0.4% INACTIVE INGREDIENTS The tablets contain colloidal silicon dioxide, croscarmellose sodium, microcrystalline cellulose and stearic acid. The solution contains alcohol (0.4%), citric acid, disodium edetate, FD&C Red #40, flavors, fructose, polyethylene glycol, potassium sorbate, sodium saccharin and water. ROXICET™ contains oxycodone, 14-hydroxydihydrocodeinone, a semisynthetic opioid analgesic which occurs as a white, odorless, crystalline powder having a saline, bitter taste. The molecular formula for oxycodone hydrochloride is C H NO · HCl and the molecular weight is 381.82. It is derived from the opium alkaloid, thebaine, and may be rep קרא את המסמך השלם